NCT00650546View on ClinicalTrials.gov

Role of Exenatide in NASH-a Pilot Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Nonalcoholic Fatty Liver Disease
Interventions
DRUG

Exenatide

5 mcg twice a day titrated to 10 mcg twice a day

Trial Locations (3)

46202

Indiana University, Indianapolis

Unknown

Kansas City VA Medical Center, Kansas City

Fort Sam Houston, San Antonio

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Indiana University

OTHER

NCT00650546 - Role of Exenatide in NASH-a Pilot Study | Biotech Hunter | Biotech Hunter